Jason Goodson - Mallinckrodt Plc Exec Devel
| MNKDelisted Stock | USD 0.46 0.02 4.17% |
Insider
Jason Goodson is Exec Devel of Mallinckrodt Plc
| Age | 42 |
| Phone | 353 1 696 0000 |
| Web | https://www.mallinckrodt.com |
Jason Goodson Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jason Goodson against Mallinckrodt Plc stock is an integral part of due diligence when investing in Mallinckrodt Plc. Jason Goodson insider activity provides valuable insight into whether Mallinckrodt Plc is net buyers or sellers over its current business cycle. Note, Mallinckrodt Plc insiders must abide by specific rules, including filing SEC forms every time they buy or sell Mallinckrodt Plc'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jason Goodson over a year ago Payment of 5545 shares by Jason Goodson of Mallinckrodt Plc subject to Rule 16b-3 | ||
Jason Goodson over a year ago Purchase by Jason Goodson of 200 shares of Mallinckrodt Plc |
Mallinckrodt Plc Management Efficiency
Mallinckrodt Plc's management efficiency ratios could be used to measure how well Mallinckrodt Plc manages its routine affairs as well as how well it operates its assets and liabilities.Mallinckrodt Plc has 3.07 B in debt with debt to equity (D/E) ratio of 1.44, which is OK given its current industry classification. Mallinckrodt Plc has a current ratio of 2.92, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Mallinckrodt to invest in growth at high rates of return.
Similar Executives
| Showing other executives | INSIDER Age | ||
| BA Esq | Organogenesis Holdings | 55 | |
| David Francisco | Organogenesis Holdings | 58 | |
| Tyvin MD | Shuttle Pharmaceuticals | 76 | |
| Robyn Hunter | Journey Medical Corp | N/A | |
| Thomas Shipley | Canopy Growth Corp | 30 | |
| Anatoly MD | Shuttle Pharmaceuticals | 80 | |
| Brian Grow | Organogenesis Holdings | 48 | |
| Tara Rozalowsky | Canopy Growth Corp | N/A | |
| Robbie Madan | SNDL Inc | 45 | |
| Robert Hanson | Canopy Growth Corp | 57 | |
| William Newlands | Canopy Growth Corp | 62 | |
| Julious Grant | Canopy Growth Corp | 56 | |
| Ernest Galvan | Journey Medical Corp | 62 | |
| Aaron Perlitsh | Lifecore Biomedical | N/A | |
| Jimes Sabia | Canopy Growth Corp | 58 | |
| Theresa Yanofsky | Canopy Growth Corp | 63 | |
| Zachary IV | SNDL Inc | 46 | |
| Kevin Gifford | Cronos Group | N/A | |
| CSC MD | Shuttle Pharmaceuticals | 57 | |
| James Holm | Cronos Group | 41 | |
| Jason Green | Canopy Growth Corp | N/A | |
Management Performance
| Return On Equity | -1.11 | |||
| Return On Asset | -0.0029 |
Mallinckrodt Plc Leadership Team
Elected by the shareholders, the Mallinckrodt Plc's board of directors comprises two types of representatives: Mallinckrodt Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mallinckrodt. The board's role is to monitor Mallinckrodt Plc's management team and ensure that shareholders' interests are well served. Mallinckrodt Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mallinckrodt Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, Global Officer | ||
| David Norton, Independent Director | ||
| Hugh ONeill, Executive Vice President and President, Autoimmune and Rare Diseases | ||
| Steven Romano, Executive Vice President and Chief Scientific Officer | ||
| Sigurdur Olafsson, Pres CEO | ||
| Mark Trudeau, CEO and President Director and Member of Portfolio Committee | ||
| Kneeland Youngblood, Independent Director | ||
| Bryan Reasons, Chief Financial Officer, Executive Vice President | ||
| Mark Casey, Executive Vice President and Chief Legal Officer | ||
| JoAnn Reed, Independent Director | ||
| J Carroll, Independent Director | ||
| Lisa French, Ex Officer | ||
| Kassie Harrold, Ex Officer | ||
| Jason Goodson, Exec Devel | ||
| Ian Watkins, Chief Human Resource Officer, Executive Vice President | ||
| Stephen Welch, Ex Generics | ||
| Henriette Nielsen, Ex Officer | ||
| Steven MD, Ex Officer | ||
| Angus Russell, Independent Non-Executive Chairman of the Board | ||
| Paul Carter, Independent Director | ||
| Carlos Paya, Independent Director | ||
| Anne Whitaker, Independent Director | ||
| Mark Tyndall, Chief VP |
Mallinckrodt Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mallinckrodt Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.11 | |||
| Return On Asset | -0.0029 | |||
| Profit Margin | (0.83) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 2.62 B | |||
| Shares Outstanding | 13.29 M | |||
| Shares Owned By Insiders | 10.09 % | |||
| Shares Owned By Institutions | 96.64 % | |||
| Number Of Shares Shorted | 1.79 M | |||
| Price To Earning | 1.09 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Mallinckrodt Stock
If you are still planning to invest in Mallinckrodt Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mallinckrodt Plc's history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |